{"entity":{"type":"insider","cik":"0001658918","url":"/insider/0001658918","json_url":"/insider/0001658918.json","name":"Kroeger Christopher A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":5,"first":"2026-04-17","last":"2026-07-17","span_basis":"filed_date"},"name_variants":[{"name":"Kroeger Christopher A.","source":"filing","n_filings":5,"first_seen":"2026-04-17","last_seen":"2026-07-17"}],"transactions":[{"id":6174516,"accession":"0001658918-26-000014","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001658918-26-000014","line_url":"/filing/0001658918-26-000014#line-7","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16779.0,"shares_display":"16,779","price_per_share":37.9,"price_display":"37.90","price_state":"stated","total_value":635924.1,"total_display":"635,924.10","total_whole":"635,924","shares_owned_after":1246455.0,"shares_owned_after_display":"1,246,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-17","scope":"insider"},{"id":6174512,"accession":"0001658918-26-000014","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001658918-26-000014","line_url":"/filing/0001658918-26-000014","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69082.0,"shares_display":"69,082","price_per_share":36.787303783908975,"price_display":"36.79","price_state":"stated","total_value":2541340.52,"total_display":"2,541,340.52","total_whole":"2,541,341","shares_owned_after":1291417.0,"shares_owned_after_display":"1,291,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-17","scope":"insider","n_lines":3},{"id":6174503,"accession":"0001658918-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001658918-26-000014","line_url":"/filing/0001658918-26-000014","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61778.0,"shares_display":"61,778","price_per_share":36.68712519019716,"price_display":"36.69","price_state":"stated","total_value":2266457.22,"total_display":"2,266,457.22","total_whole":"2,266,457","shares_owned_after":1332406.0,"shares_owned_after_display":"1,332,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider","n_lines":3},{"id":5803000,"accession":"0001658918-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001658918-26-000012","line_url":"/filing/0001658918-26-000012","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118235.0,"shares_display":"118,235","price_per_share":27.191607645790164,"price_display":"27.19","price_state":"stated","total_value":3214999.73,"total_display":"3,214,999.73","total_whole":"3,215,000","shares_owned_after":1394292.0,"shares_owned_after_display":"1,394,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-18","scope":"insider","n_lines":2},{"id":6157676,"accession":"0001658918-26-000010","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001658918-26-000010","line_url":"/filing/0001658918-26-000010","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13980.0,"shares_display":"13,980","price_per_share":30.11459799713877,"price_display":"30.11","price_state":"stated","total_value":421002.08,"total_display":"421,002.08","total_whole":"421,002","shares_owned_after":1518219.0,"shares_owned_after_display":"1,518,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-05-11","scope":"insider","n_lines":4},{"id":6157664,"accession":"0001658918-26-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001658918-26-000010","line_url":"/filing/0001658918-26-000010","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34411.0,"shares_display":"34,411","price_per_share":27.689850338554532,"price_display":"27.69","price_state":"stated","total_value":952835.44,"total_display":"952,835.44","total_whole":"952,835","shares_owned_after":1531096.0,"shares_owned_after_display":"1,531,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-08","filed_date":"2026-05-11","scope":"insider","n_lines":3},{"id":6157655,"accession":"0001658918-26-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001658918-26-000010","line_url":"/filing/0001658918-26-000010","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20100.0,"shares_display":"20,100","price_per_share":28.646597014925373,"price_display":"28.65","price_state":"stated","total_value":575796.6,"total_display":"575,796.60","total_whole":"575,797","shares_owned_after":1565940.0,"shares_owned_after_display":"1,565,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-07","filed_date":"2026-05-11","scope":"insider","n_lines":2},{"id":6045012,"accession":"0001658918-26-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001658918-26-000008","line_url":"/filing/0001658918-26-000008","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23701.0,"shares_display":"23,701","price_per_share":28.75757605164339,"price_display":"28.76","price_state":"stated","total_value":681583.31,"total_display":"681,583.31","total_whole":"681,583","shares_owned_after":1580820.0,"shares_owned_after_display":"1,580,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-06","scope":"insider","n_lines":2},{"id":6045006,"accession":"0001658918-26-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001658918-26-000008","line_url":"/filing/0001658918-26-000008","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10472.0,"shares_display":"10,472","price_per_share":28.19798319327731,"price_display":"28.20","price_state":"stated","total_value":295289.28,"total_display":"295,289.28","total_whole":"295,289","shares_owned_after":1605449.0,"shares_owned_after_display":"1,605,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-06","scope":"insider","n_lines":2},{"id":6044998,"accession":"0001658918-26-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001658918-26-000008","line_url":"/filing/0001658918-26-000008","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15571.0,"shares_display":"15,571","price_per_share":27.959855500610107,"price_display":"27.96","price_state":"stated","total_value":435362.91,"total_display":"435,362.91","total_whole":"435,363","shares_owned_after":1621428.0,"shares_owned_after_display":"1,621,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-06","scope":"insider","n_lines":4},{"id":6174491,"accession":"0001658918-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001658918-26-000006","line_url":"/filing/0001658918-26-000006","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10052.0,"shares_display":"10,052","price_per_share":27.371719060883407,"price_display":"27.37","price_state":"stated","total_value":275140.52,"total_display":"275,140.52","total_whole":"275,141","shares_owned_after":1630564.0,"shares_owned_after_display":"1,630,564","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-16","filed_date":"2026-04-17","scope":"insider","n_lines":2},{"id":6174484,"accession":"0001658918-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001658918-26-000006","line_url":"/filing/0001658918-26-000006#line-1","is_derivative":false,"issuer_cik":"0001658918","issuer_name":"MapLight Therapeutics, Inc.","issuer_ticker":"MPLT","issuer_name_source":null,"issuer_url":"/issuer/0001658918","owner_cik":"0001658918","owner_name":"Kroeger Christopher A.","owner_display_name":"Kroeger Christopher A.","owner_url":"/insider/0001658918","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9135.0,"shares_display":"9,135","price_per_share":26.93,"price_display":"26.93","price_state":"stated","total_value":246005.55,"total_display":"246,005.55","total_whole":"246,006","shares_owned_after":1640616.0,"shares_owned_after_display":"1,640,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001770069","name":"MapLight Therapeutics, Inc.","url":"/issuer/0001770069","role":"Director, Officer (Chief Executive Officer)","n_filings":5,"first_seen":"2026-04-17","last_seen":"2026-07-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001658918","retrieved_at":"2026-08-25T07:05:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}